Vir Biotechnology, Inc.’s Post

Chief Technology Officer (CTO), EVP Technical Operations & Quality at Vir Biotechnology & NIBRT Board member.

3mo Edited

I’m looking forward to participating on a panel discussion this week on “Getting to Regulatory Approval” at the @Longwood Healthcare Leaders Spring MIT forum. This meeting is Co-hosted by Professors Phil Sharp and Bob Langer and held at MIT’s Koch Institute, June 17-18, and includes a broad spectrum of topics affecting the biopharma ecosystem. @longwoodhealthcareleaders @longwoodfund #longwoodhealthcareleaders #virbio

To view or add a comment, sign in

More Relevant Posts

Vir Biotechnology, Inc.

32,481 followers
4d
Report this post
The World Hepatitis Alliance's Hepatitis Delta Global Landscape Survey is now live, and your participation is crucial. By taking just a few minutes to complete this survey, you'll be contributing to a global effort to gather comprehensive data that can drive meaningful action. Together, we can push for better awareness, more comprehensive screening, and stronger support systems for those impacted by Hepatitis Delta. Click the link below to make your voice heard! 🌐 Vir is a sponsor of the Hepatitis Delta Global Landscape Survey https://bit.ly/4eS3hvb
Like Comment
To view or add a comment, sign in
Vir Biotechnology, Inc.

32,481 followers
1w
Report this post
Join our Chief Medical Officer, Mark Eisner, for a fireside chat at the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference where he will share perspectives on Vir’s Hepatitis Delta and B programs. ➡️ Sign up here: https://lnkd.in/gHAxzPPZ
Like Comment
To view or add a comment, sign in
Vir Biotechnology, Inc.

32,481 followers
1w
Report this post
Nasdaq at Times Square lights up for Jason O'Byrne, Vir’s new Executive Vice President and CFO as he joins us this week. We are #VirProud to welcome him as part of the team and wish him every success. Welcome, Jason!
31 Comments
Like Comment
To view or add a comment, sign in
Vir Biotechnology, Inc.

32,481 followers
1w
Report this post
Congratulations and proficiat to our CEO Marianne De Backer, MSc, PhD, MBA on her recognition as Ghent University’s Alumnus of the Year 2024! We are #VirProud about this recognition of Marianne’s career and testament to her #leadership, dedication, and contributions to accelerating innovation for those who need it most.
Marianne D. De Backer, MSc, PhD, MBA

CEO Vir Biotechnology, Inc. Board Member. Passionate about making a difference for patients.
1w

Stories are powerful: through them we share, we inspire, and we organize to take action, making the impossible a reality. I had the opportunity to share my story yesterday as I received the Alumnus of the year 2024 award from Rector Rik Van De Walle at Universiteit Gent. It was an honor for me to be recognized for my career and to share some of the moments that have shaped me into who I am today, some of which happened right at this university. After this chance to reflect and celebrate with peers, mentors, and family, it's time to get back to work: patients are waiting, and we're on a mission to change that at Vir Biotechnology, Inc.!
2 Comments
Like Comment
To view or add a comment, sign in
Vir Biotechnology, Inc.

32,481 followers
3w
Report this post
Vir welcomes Dr. Mika Kakefuda Derynck as Executive Vice President of Therapeutic Oncology. She brings over 30 years of experience in cancer research and drug development in areas of high unmet need and limited options for patients. Her focus is driving development of masking and other innovative technologies in oncology to demonstrate benefit and expedite approvals of immunotherapies for solid tumors. Read more about our expanded areas of focus: https://lnkd.in/gQQvnrYB
2 Comments
Like Comment
To view or add a comment, sign in
Vir Biotechnology, Inc.

32,481 followers
1mo
Report this post
Curious about what Vir Biotechnology, Inc.'s exclusive worldwide license agreement with Sanofi means for us? Marianne De Backer, MSc, PhD, MBA reflects on the news. Read all about it here: https://lnkd.in/gnBcDN2h
Marianne D. De Backer, MSc, PhD, MBA

CEO Vir Biotechnology, Inc. Board Member. Passionate about making a difference for patients.
1mo

It is an exhilarating week for Vir Biotechnology, Inc. and for me personally! I am excited to welcome a new team of skilled scientists to Vir with a passion to progress science for patients! We have successfully closed our exclusive worldwide license agreement with Sanofi. Beyond bolstering our clinical pipeline with three T cell engagers in #oncology, we are also complementing our world-class #antibody platform with the highly synergistic and pre-clinically validated PRO-XTEN #masking platform. The potential of these combined platforms in #cancer and #infectiousdisease is immense. I am already looking forward to the impact we will have as we work together to transform the lives of #patients. #PatientsAreWaiting #Tcellengagers #PoweringTheImmuneSystemToTransformLives #TeamVir
3 Comments
Like Comment
To view or add a comment, sign in
Vir Biotechnology, Inc.

32,481 followers
1mo
Report this post
🌟 Exciting News at Vir Biotechnology! 🌟 We are pleased to announce the appointment of Jason O'Byrne as our new Chief Financial Officer effective Oct 02, 2024. To learn more about the experience and expertise Mr. O’Byrne will bring to Vir, please check out our press release: https://lnkd.in/g_BE4a9i #TeamVir #CFO

Vir Biotechnology Appoints Jason O’Byrne as Chief Financial Officer

investors.vir.bio

32 Comments
Like Comment
To view or add a comment, sign in
Vir Biotechnology, Inc.

32,481 followers
1mo
Report this post
📣 NEWS 📣 Today we execute on our expanded strategy to consolidate our growth beyond #InfectiousDiseases. We are proud to bring on board three clinical-stage masked T-cell engagers with potential applications in #oncology and exclusive use of the proprietary PRO-XTEN platform in oncology and infectious disease. ➡️ Read about it here: https://lnkd.in/gnBcDN2h
4 Comments
Like Comment
To view or add a comment, sign in
Vir Biotechnology, Inc.

32,481 followers
1mo
Report this post
Reminder: Join Marianne De Backer, MSc, PhD, MBA, tomorrow, September 5, for a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference. Sign up and join the webcast here: https://lnkd.in/gZiiG_xC
Like Comment
To view or add a comment, sign in
Vir Biotechnology, Inc.

32,481 followers
1mo Edited
Report this post
Tune in September 5 for a fireside chat with Marianne De Backer, MSc, PhD, MBA, at the Morgan Stanley 22nd Annual Global Healthcare Conference. Learn more here: https://lnkd.in/gnHDn4-3
1 Comment
Like Comment
To view or add a comment, sign in

32,481 followers

View Profile Follow

Vir Biotechnology, Inc.’s Post

More from this author

Unveiling the Silent Threat: Surprising Facts About Chronic Hepatitis Delta

Meet Mark Eisner: An Interview with Vir's New EVP and Chief Medical Officer

Promising Preliminary Results from Our Broad Hepatitis Clinical Program

Explore topics